Objective
This proposal aims at the fast-track pharmaceutical development and clinical validation of two artesunate-based fixed-dose combinations for the treatment of malaria, including the preparation of relevant registration files. The goal is to make these new combination drugs available for use as quality, safe, viable, adapted and affordable drugs in the endemic countries. This project constitutes a missing link in promoting antimalarial policy changes towards combination therapy, and the successful implementation thereof. It builds upon the expertises of R& D centres in the EU and different regions in the South, which are being mobilised in an international effort to dramatically improve the available malaria treatment tools.
Fields of science
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
75015 PARIS
France